You are on Trendlyne United States. Click here to go to India website or make United States as your default

Darren S. Cline's Insider Trades & SAST Disclosures

Darren S. Cline's most recent trade in Pliant Therapeutics Inc was a trade of 26,764 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pliant Therapeutics Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 26,764 26,764 - - Common Stock (Right to Buy)
Pyxis Oncology Inc
Cline Darren S. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 35,219 251,405 - 0 Common Stock
Impel Pharmaceuticals Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 13,222 13,222 - - Stock Option (right to buy)
Pliant Therapeutics Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 14,000 14,000 - - Stock Option (Right to Buy)
Impel Pharmaceuticals Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2023 20,013 20,013 - - Stock Option (right to buy)
Pyxis Oncology Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2023 139,355 216,186 - 0 Common Stock
Pliant Therapeutics Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 22,000 22,000 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 66,831 76,831 - 0 Common Stock
Pyxis Oncology Inc
Darren S. Cline Director Purchase of securities on an exchange or from another person at price $ 9.39 per share. 08 Dec 2021 10,000 10,000 - 9.4 93,885 Common Stock
Pyxis Oncology Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2021 42,191 42,191 - - Stock Option (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades